Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

PubWeight™: 7.12‹?› | Rank: Top 1%

🔗 View Article (PMID 32171062)

Published in Lancet Respir Med on March 11, 2020

Authors

Lei Fang1, George Karakiulakis2, Michael Roth3

Author Affiliations

1: Pulmonary Cell Research and Pneumology, Department of Biomedicine and Internal Medicine, University Hospital Basel, CH-4031 Basel, Switzerland.
2: Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
3: Pulmonary Cell Research and Pneumology, Department of Biomedicine and Internal Medicine, University Hospital Basel, CH-4031 Basel, Switzerland. Electronic address: michael.roth@usb.ch.

Associated clinical trials:

Risk Factors Worsening COVID19 for Out-patient With Home Monitoring (COVIDADOMEVA) | NCT04380662

Articles by these authors

Antihypertensive drugs and risk of COVID-19? - Authors' reply. Lancet Respir Med (2020) 0.75